The long-term goal is to provide new and improved analytical methods that will enable researchers to find gene markers genetically linked with the putative gene(s) for schizophrenia. This, in turn, will open the way to identifying the schizophrenia gene(s). Once such genes are found, there is hope that knowledge of their structure will lead to a deeper understanding of the disease etiology and, thus, to the possibility of ameliorating or curing schizophrenia.
The specific aims consist of developing more efficient methods of linkage analysis than have previously been employed. Also, automated computer- based methods will be developed to allow researchers to decide which families and which family members in a family to ascertain so as to maximize linkage information with a minimum of individuals tested. Nonparametric methods will be extended to allow for phenocopies (affected sib pair methods) and for both recombination and linkage disequilibrium (haplotype relative risk statistic). New likelihood methods of linkage analysis will be derived by focusing attention on a subset of disease phenotypes so as to reduce dependency on model assumptions, by allowing for an oligogenic rather than a monogenic mode of inheritance of schizophrenia, and by considering disease status jointly with biological indicator variables as a multivariate phenotype. The methods will be obtained by statistical investigation and will be implemented in computer programs, partly by modifying existing multi-point computer programs. Programs and methods will be made available to researchers and will also be applied to schizophrenia families collected by other researchers, particularly those of Dr. Baron.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH044292-01A1
Application #
3383815
Study Section
Epidemiologic and Services Research Review Committee (EPS)
Project Start
1989-05-01
Project End
1992-04-30
Budget Start
1989-05-01
Budget End
1990-04-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Xu, Haiyan; Cheng, Rong; Juo, Suh-Hang et al. (2011) Fine mapping of candidate regions for bipolar disorder provides strong evidence for susceptibility loci on chromosomes 7q. Am J Med Genet B Neuropsychiatr Genet 156:168-76
He, C; Hamon, S; Li, D et al. (2009) MHC fine mapping of human type 1 diabetes using the T1DGC data. Diabetes Obes Metab 11 Suppl 1:53-9
Cheung, Kenneth M C; Karppinen, Jaro; Chan, Danny et al. (2009) Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 34:934-40
Nielsen, David A; Yuferov, Vadim; Hamon, Sara et al. (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 34:867-73
Long, Quan; Zhang, Qingrun; Ott, Jurg (2009) Detecting disease-associated genotype patterns. BMC Bioinformatics 10 Suppl 1:S75
Yuferov, Vadim; Ji, Fei; Nielsen, David A et al. (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34:1185-97
Levran, O; Londono, D; O'Hara, K et al. (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531-40
Harris, C R; Dewan, A; Zupnick, A et al. (2009) p53 responsive elements in human retrotransposons. Oncogene 28:3857-65
Andreoli, Michael T; Morrison, Margaux A; Kim, Ben J et al. (2009) Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. Am J Ophthalmol 148:869-74
Porton, Barbara; Delisi, Lynn E; Bertisch, Hilary C et al. (2008) Telomerase levels in schizophrenia: a preliminary study. Schizophr Res 106:242-7

Showing the most recent 10 out of 61 publications